High-sensitivity cardiac troponin I as a reliable prognosis biomarker in patients with hypertrophic cardiomyopathy
BACKGROUND: Hypertrophic cardiomyopathy (HCM) is the most common inherited
cardiac disease and is associated with increased risk of cardiovascular events. For risk
assessment, guidelines recommend carrying out different tests during follow-up.
However, the role of plasma biomarkers such as serum high-sensitivity cardiac troponin-
I (hs-cTnI) has not yet been well established. To get more data, we analyzed the
relationships between this biomarker and clinical and imaging parameters.
METHODS: W...